A New Case of Schnitzler Syndrome in Bulgaria

1. Lipsker D. The Schnitzler syndrome. Orphanet Journal of Rare Diseases, 2010, 5 (38), 1-8.10.1186/1750-1172-5-38301845421143856Search in Google Scholar

2. De Koning H. Schnitzler’s syndrome: lessons from 281 cases. Clinical and Translational Allergy, 2014, 4(41), 1-15.10.1186/2045-7022-4-41440582725905009Search in Google Scholar

3. Simon A, Asli B, Braun-Falco M, et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy, 2013, 68, 562-568.10.1111/all.1212923480774Search in Google Scholar

4. Soubrier M. Schnitzler syndrome. Joint Bone Spine, 2008, 75, 263-266.10.1016/j.jbspin.2007.07.01418378180Search in Google Scholar

5. Sokumbi O, Drage L, Peters M, et al. Clinical and histopatho-logic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011). J Am Acad Dermatol., 2012, 67(6), 1289-95.10.1016/j.jaad.2012.04.02722627038Search in Google Scholar

6. de Koning H, Bodar E, Meer J, et al. Schnitzler syndrome: Beyond the case reports: Review and follow-up of 94 patients with an emphasis on prognosis and treatment. Seminars in Arthritis and Rheumatism., 2007, 37, 137-148.10.1016/j.semarthrit.2007.04.00117586002Search in Google Scholar

7. Terpos E, Asli B, Christoulas D. et al. Increased angiogenesis and enhanced bone formation in patients with IghM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome. Haematologica, 2012, 97(11), 1699-1703.10.3324/haematol.2012.067306348744322689688Search in Google Scholar

8. Lim W, Shumak K, Reis M, et al. Malignant evolution of Schnitzler’s Syndrome: chronic urticarial and IgM monoclonal gammopathy: report of a new case and review of the literature. Leuk Lymphoma, 2002, 43,181-8.10.1080/1042819021018111908725Search in Google Scholar

9. Koch A, Tchernev G, Chokoeva A. Schnitzler syndrome responding to Interleukin-1 antagonist Anakinra. Journal of biological regulators &homeostatic agents, 2015, 29, 2 (S).Search in Google Scholar

10. Kamusheva M, Donev S, Kirilova-Doneva M, et al. Direct medical costs for treatment of Schnitzler syndrome – a case study. Rare disease, 2017, 8(1), 3-6.Search in Google Scholar

11. Lipsker D, Spehner D, Drillien R, et al. Schitzler syndrome: heterogeneous immunopathological findings involving IgM skin interactions. Br J Drematol., 2000, 142,954-959.10.1046/j.1365-2133.2000.03477.x10809854Search in Google Scholar

12. Lipsker D, Veran Y, Grunenberger F et al. The Schitzler syndrome. Four new cases and review of the literature. Medicine, 2001, 80, 37-44.10.1097/00005792-200101000-0000411204501Search in Google Scholar

13. Krause K, Weller K, Stefaniak R, et al. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy, 2012, 67(7), 943-950.10.1111/j.1398-9995.2012.02843.xSearch in Google Scholar

14. Jarrett P. Schnitzler syndrome. 2009; Available from: http://www.dermnetnz.org/topics/schnitzler-syndromeSearch in Google Scholar

15. Bozeman S, Lewis S. Schnitzler syndrome successfully treated with methotrexate. Ann Allergy Asthma Immunol., 2008, 101(2), 219-225.10.1016/S1081-1206(10)60213-XSearch in Google Scholar

16. Peterlana D, Puccetti A, Tinazzi E, et al. Schnitzler’s syndrome treated successfully with intravenous pulse cyclophosphamide-to suppress the immune system. Scand J Rheumatol., 2005, 34(4), 328-30.10.1080/0300974051001773316195169Search in Google Scholar